exoIL-12

N/A

Report date: 2025/02/28 10:17:03

Base Information

Drug NameexoIL-12
Drug Alias Name白细胞介素-12外泌体exosome-delivered IL-12exoIL 12exoInterleukin-12CDK-003 +[6] 
ClassificationBiologics > Exosomes
Mechanisms of ActionInterleukin-12 receptor modulators
TargetsInterleukin-12 receptor
Therapy Area/IndicationsLymphoma, T-Cell, Cutaneous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCodiak Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCodiak Biosciences
Active IndicationsN/A
Inactive IndicationsLymphoma, T-Cell, Cutaneous

Other Information

ATC CodeN/A
Related LinksN/A